Crossmark

Is it the time to include transgender women in risk groups for human papillomavirus vaccination?

Crossref DOI link: https://doi.org/10.1016/j.vacune.2022.10.001

Published Print: 2022-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dominguez-Riscart, Jesus

Mateo-Gavira, Isabel

Martin-Aspas, Andres
License Information

Text and Data Mining valid from 2022-09-01
More Information

This article is maintained by: Elsevier

Article Title: Is it the time to include transgender women in risk groups for human papillomavirus vaccination?

Journal Title: Vacunas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacune.2022.10.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.vacun.2022.07.002

Content Type: simple-article

Copyright: © 2022 Published by Elsevier España, S.L.U.